EUVIMEDEUVIMED entdecken
EditorialLeitlinie

Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines

David Groheux, Sofia C Vaz, Gary A Ulaner, Gary J R Cook, John Patrick Pilkington Woll, Ritse M Mann, Philip Poortmans, Fatima Cardoso, Heather Jacene, Stephanie L Graff, Isabel T Rubio, Marie-Jeanne Vrancken Peeters und 2 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2024-07 · 51 (9) · 2701-2705

DOI: 10.1007/s00259-024-06694-x ↗

Kurz gefasst

Editorial in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 02.05.2024. Verfasst von David Groheux und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Saint-Louis Hospital, Paris, France. dgroheux@yahoo.fr. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Breast Neoplasms, Fluorodeoxyglucose F18, Practice Guidelines as Topic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyBreast NeoplasmsFluorodeoxyglucose F18Practice Guidelines as TopicHumansEuropeUnited StatesNuclear MedicineFemaleSocieties, MedicalRadiopharmaceuticals

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Nuclear Medicine Department, Saint-Louis Hospital, Paris, France. dgroheux@yahoo.fr.
  • University Paris-Diderot, INSERM U976, Paris, France. dgroheux@yahoo.fr.
  • Centre d'Imagerie Radio-Isotopique (CIRI), La Rochelle, France. dgroheux@yahoo.fr.
  • Nuclear Medicine-Radiopharmacology, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA, USA.

Zitieren

APA

Groheux, D., Vaz, S. C., Ulaner, G. A., Cook, G. J. R., Woll, J. P. P., Mann, R. M., Poortmans, P., Cardoso, F., Jacene, H., Graff, S. L., Rubio, I. T., Peeters, M. V., Dibble, E. H., & de Geus-Oei, L. F. (2024). Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines. European Journal of Nuclear Medicine and Molecular Imaging, 51(9), 2701-2705. https://doi.org/10.1007/s00259-024-06694-x

Vancouver

Groheux D, Vaz SC, Ulaner GA, Cook GJR, Woll JPP, Mann RM, et al. Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines. European Journal of Nuclear Medicine and Molecular Imaging. 2024;51(9):2701-2705. doi:10.1007/s00259-024-06694-x

BibTeX
@article{Groheux2024,
  author = {Groheux, David and Vaz, Sofia C and Ulaner, Gary A and Cook, Gary J R and Woll, John Patrick Pilkington and Mann, Ritse M and Poortmans, Philip and Cardoso, Fatima and Jacene, Heather and Graff, Stephanie L and Rubio, Isabel T and Peeters, Marie-Jeanne Vrancken and Dibble, Elizabeth H and de Geus-Oei, Lioe-Fee},
  title = {Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  volume = {51},
  number = {9},
  pages = {2701--2705},
  doi = {10.1007/s00259-024-06694-x}
}
Kostenlos starten →